Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
OCGN · against 307 other Healthcare companies of similar size
Ranked #196 of 308 · scores higher than 12% of peers
Bars: peers in each 10-point band of the valuation score113 peers with a valuation score of 0–9, including OCGN · Click a bar to see the companies
Mainly because of its earnings yield, EBITDA yield and free cash flow yield, which are weaker than most Healthcare peers.
| Metric | OCGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 293 reported | -33.6% | -0.5% | 14% | 30% | |
| EBITDA yieldHigher is better · 314 reported | -27.9% | 1.9% | 16% | 50% | |
| Free cash flow yieldHigher is better · 165 reported | -24.2% | -9.5% | 26% | 20% | |
| Book yieldHigher is better · 297 reported | -6.6% | 55.0% | 5% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 1.4B HKD (≈$181M) | 99 | 61 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 196 | 366M CHF (≈$421M) | 8 | 23 | |
| 196 | 299M USD | 8 | 38 | |
| 196 | 423M USD | 8 | 29 | |
| 196 | 334M USD | 8 | 49 | |
| 196 | 253M USD | 8 | 15 | |
| 196 | 469M USD | 8 | 45 | |
| 196 | 170M USD | 8 | 35 | |
| 196 | 302M USD | 8 | 42 | |
| 196 | 427M USD | 8 | 7 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score